Skip to main content
Clinical Trials/NL-OMON29827
NL-OMON29827
Completed
Not Applicable

The application of autologous platelet rich fibrin reduces allogeneic blood transfusions and improves wound healing in total hip arthroplasty - Platelet rich fibrin in THA (total hip arthroplasty)

Catharina-ziekenhuis0 sites152 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
coxarthrosis
Sponsor
Catharina-ziekenhuis
Enrollment
152
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • patients with primary ostheoarthritis who need total hip arthroplasty

Exclusion Criteria

  • coagulation diseases, use of anticoagulant drugs, renal problems or failure, liver disease, and malignant disease

Outcomes

Primary Outcomes

Not specified

Similar Trials